aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Engage Bio: Pioneering mRNA treatments to target and eliminate cancer.
Engage Bio, founded by experts in immunotherapy and mRNA therapeutics, is committed to developing mRNA immunotherapies to combat cancer. The company focuses on transforming cancer cells into factories for therapeutic proteins, enabling localized treatment that targets tumors while sparing healthy tissues. Engage Bio's innovative approach aims to provide effective cancer treatment with minimal side effects, positioning it at the forefront of oncology therapeutics.
Notable figures affiliated with Engage Bio include its founders, who have a proven track record with four drugs already in clinical trials. The company has attracted significant interest from investors due to its pioneering technology and potential for high impact in cancer treatment. Engage Bio's achievements in advancing mRNA therapies underscore its potential to revolutionize cancer care, making a significant impact on patient outcomes and the broader medical community.
Operating Status
Active
Ownership Type(s)
Venture Capital, Private
Main Product(s)
Cancer Treatment, Immunotherapy
Technology
mRNA
Tags
Healthtech
Model Types
Biotech
Revenue Type(s)
Consulting
Customer Type(s)
Enterprise
Geographic Exposure
United States
When was Engage Bio founded?
Engage Bio was founded in 2021.
Where is Engage Bio’s headquarters located?
Engage Bio’s headquarters is located in San Carlos, CA, US.
When was Engage Bio’s last funding round?
Engage Bio’s most recent funding round was for $3.9M (USD) in May 2022.
How many employees does Engage Bio have?
Engage Bio has 6 employees as of Feb 4, 2024.
How much has Engage Bio raised to-date?
As of July 05, 2023, Engage Bio has raised a total of $3.9M (USD) since May 1, 2022.
Add Comparison
Total Raised to Date
$3.9M
USD
Last Update May 1, 2022
Last Deal Details
$3.9M
USD
May 1, 2022
Seed
Total Employees Over Time
6
As of Feb 2024
Engage Bio Address
San Carlos,
California
94070
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts